Ventilator performances for non-invasive ventilation: a bench study.


Journal

BMJ open respiratory research
ISSN: 2052-4439
Titre abrégé: BMJ Open Respir Res
Pays: England
ID NLM: 101638061

Informations de publication

Date de publication:
22 Oct 2024
Historique:
received: 19 10 2023
accepted: 16 09 2024
medline: 23 10 2024
pubmed: 23 10 2024
entrez: 22 10 2024
Statut: epublish

Résumé

A wide range of recent ventilators, dedicated or not, is available for non-invasive ventilation (NIV) in respiratory or intensive care units (ICU). We conducted a bench study to compare their technical performances. Ventilators, including five ICU ventilators with NIV mode on, two dedicated NIV ventilators and one transport ventilator, were evaluated on a test bench for NIV, consisting of a 3D manikin head connected to an ASL 5000 lung model via a non-vented mask. Ventilators were tested according to three simulated lung profiles (normal, obstructive, restrictive), three levels of simulated air leakage (0, 15, 30 L/min), two levels of pressure support (8, 14 cmH The global median Asynchrony Index (AI) was higher with ICU ventilators than with dedicated NIV ventilators (4% (0; 76) vs 0% (0; 15), respectively; p<0.05) and different between all ventilators (p<0.001). The AI was higher with ICU ventilators for the normal and restrictive profiles (p<0.01) and not different between ventilators for the obstructive profile. Auto-triggering represented 43% of all patient-ventilator asynchrony. Triggering delay, cycling delay, inspiratory pressure-time product, pressure rise time and pressure at mask were different between all ventilators (p<0.01). Dedicated NIV ventilators induced a lower pressure-time product than ICU and transport ventilators (p<0.01). There was no difference between ventilators for minute ventilation and peak flow. Despite the integration of NIV algorithms, most recent ICU ventilators appear to be less efficient than dedicated NIV ventilators. Technical performances could change, however, according to the underlying respiratory disease and the level of air leakage.

Identifiants

pubmed: 39438080
pii: 11/1/e002144
doi: 10.1136/bmjresp-2023-002144
pii:
doi:

Types de publication

Journal Article Comparative Study

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: Christian Caillard reports non-financial support from Asten. Christophe Girault reports grants and non-financial support from Fischer & Paykel Healthcare, Resmed Ltd., Loweinstein Medical, Asten, outside the submitted work. Antoine Cuvelier, Maxime Patout, Emeline Fresnel, Fabienne Tamion and Elise Artaud-Macari have nothing to disclose.

Auteurs

Christian Caillard (C)

Intensive Care Unit, Intercommunal Hospital Centre Elbeuf-Louviers-Val de Reuil, Saint Aubin les Elbeuf, France chricaillard@gmail.com.
Medical Intensive Care Department, CHU Rouen, Rouen, France.
Normandie Univ, UNIROUEN, UR 3830, Institute for Research and Innovation in Biomedicine (IRIB), Rouen, France.

Emeline Fresnel (E)

Normandie Univ, UNIROUEN, UR 3830, Institute for Research and Innovation in Biomedicine (IRIB), Rouen, France.
Kernel Biomedical, Rouen, France.

Elise Artaud-Macari (E)

Normandie Univ, UNIROUEN, UR 3830, Institute for Research and Innovation in Biomedicine (IRIB), Rouen, France.
Pulmonology, Thoracic Oncology and Respiratory Intensive Care Department, CHU de Rouen, Rouen, France.

Antoine Cuvelier (A)

Normandie Univ, UNIROUEN, UR 3830, Institute for Research and Innovation in Biomedicine (IRIB), Rouen, France.
Pulmonology, Thoracic Oncology and Respiratory Intensive Care Department, CHU de Rouen, Rouen, France.

Fabienne Tamion (F)

Medical Intensive Care Department, CHU Rouen, Rouen, France.
Normandie Univ, UNIROUEN, Inserm U1096, Institute for Research and Innovation in Biomedicine (IRIB), Rouen, France.

Maxime Patout (M)

La Pitié-Salpétrière University Hospital, Pulmonology and Sleep Department, Sorbonne University, Paris, France.

Christophe Girault (C)

Medical Intensive Care Department, CHU Rouen, Rouen, France.
Normandie Univ, UNIROUEN, UR 3830, Institute for Research and Innovation in Biomedicine (IRIB), Rouen, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH